Hebert, Adelaide, Rhonda Schrieber, Debbie Glaab, and Lawrence Eichenfield. “Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol Propionate Foam, 0.05% in Adolescent Subjects With Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s77. Accessed January 24, 2021. https://jofskin.org/index.php/skin/article/view/1110.